DNA Topoisomerase II as the Cellular Target of a Novel Antitumor Agent ICRF-193, a Bisdioxopiperazine Derivative, inXenopusEgg Extract
- 27 June 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 235 (3) , 571-575
- https://doi.org/10.1006/bbrc.1997.6851
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 29 references indexed in Scilit:
- ICRF-193, an Inhibitor of Topoisomerase II, Demonstrates That DNA Replication in Sperm Nuclei Reconstituted in Xenopus Egg Extracts Does Not Require Chromatin DecondensationExperimental Cell Research, 1995
- Synthesis of Simian Virus 40 C-family Catenated Dimersin Vivoin the Presence of ICRF-193Journal of Molecular Biology, 1995
- Sister chromatid separation in frog egg extracts requires DNA topoisomerase II activity during anaphaseThe Journal of cell biology, 1992
- Cell cycle control of higher-order chromatin assembly around naked DNA in vitro.The Journal of cell biology, 1991
- Characterization of the ooplasmic factor inducing decondensation of and protamine removal from toad sperm nuclei: Involvement of nucleoplasminDevelopmental Biology, 1991
- Sperm decondensation in Xenopus egg cytoplasm is mediated by nucleoplasminCell, 1991
- Mitotic chromatin condensation in vitro using somatic cell extracts and nuclei with variable levels of endogenous topoisomerase II.The Journal of cell biology, 1990
- Disassembly of the nucleus in mitotic extracts: Membrane vesicularization, lamin disassembly, and chromosome condensation are independent processesCell, 1987
- Formation in Vitro of Sperm Pronuclei and Mitotic Chromosomes Induced by Amphibian Ooplasmic ComponentsScience, 1983
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969